Glaucoma implant could replace daily eye drops
NCT ID NCT07075718
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a second-generation travoprost implant placed inside the eye to lower pressure in people with open-angle glaucoma or ocular hypertension. About 610 participants will receive either the implant, timolol eye drops, a sham procedure, or placebo drops. The main goal is to see if the implant safely reduces eye pressure over three months.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
travoprost implant
What this could lead to
If successful, this implant could offer a long-lasting way to lower eye pressure in glaucoma patients, reducing the need for daily eye drops.
What could go wrong
This is an early-to-mid stage trial, so the implant may not work as well as hoped or could cause side effects like eye irritation or vision changes. It is also compared to standard drops, so benefits over current care are not guaranteed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLAUCOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Glaukos Clinical Site
RECRUITINGEl Paso, Texas, 79922, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Glaukos Investigative Site
RECRUITINGGrand Junction, Colorado, 81501, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Glaukos Investigative Site
RECRUITINGOklahoma City, Oklahoma, 73112, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••